ArticleFrontiers in pharmacology2024

Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study.

Yoshimi Muta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.